 | Up a level |
Bejanyan, Nelli; Zhang, Meijie; Bo-Subait, Khalid; Brunstein, Claudio; Wang, Hailin; Warlick, Erica D; Giralt, Sergio; Nishihori, Taiga; Martino, Rodrigo; Passweg, Jakob; Dias, Ajoy; Copelan, Edward; Hale, Gregory; Gale, Robert Peter; Solh, Melhem; Kharfan-Dabaja, Mohamed A; Diaz, Miguel Angel; Ganguly, Siddhartha; Gore, Steven; Verdonck, Leo F; ... (2021). Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study. Biology of blood and marrow transplantation, 27(1), 68.e1-68.e9. Elsevier 10.1016/j.bbmt.2020.09.026
Zhou, Zheng; Nath, Rajneesh; Cerny, Jan; Wang, Hai-Lin; Zhang, Mei-Jie; Abdel-Azim, Hisham; Agrawal, Vaibhav; Ahmed, Gulrayz; Al-Homsi, A Samer; Aljurf, Mahmoud; Alkhateeb, Hassan B; Assal, Amer; Bacher, Vera; Bajel, Ashish; Bashir, Qaiser; Battiwalla, Minocher; Bhatt, Vijaya Raj; Byrne, Michael; Cahn, Jean-Yves; Cairo, Mitchell; ... (2020). Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood advances, 4(13), pp. 3180-3190. American Society of Hematology 10.1182/bloodadvances.2019001266
